Arca
Skip to content
Tools
Tools

Stomach cancer

Drug research and approvals for stomach cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 737 studies of stomach cancer are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 3 open orphan designations naming it.

  • Recruiting worldwide: 737
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 737 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 5

Phase 3 12 of 59

Phase 2 12 of 107

Phase 1 or earlier 12 of 52

How its trials ended

2,355 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 371 whose ending is known, 38% met their primary endpoint, 12% missed it and 50% stopped early.

  • Completed, result not reported69630%
  • Ongoing66928%
  • Status unknown61926%
  • Met its primary endpoint1406%
  • Stopped: other or unclear874%
  • Stopped: enrollment or feasibility472%
  • Missed its primary endpoint462%
  • Stopped: sponsor or business decision281%
  • Stopped: lack of efficacy161%
  • Stopped: safety6<1%
  • Stopped: funding1<1%

FDA orphan designations

Approved first, then open designations, newest first
Dec 10, 20257-ethtyl-10-hydroxycamptothecin and irinotecanTreatment of stomach cancer (including gastroesophageal junction cancer)SN BioScience Inc.Designated
May 29, 2007PlevitrexedTreatment of gastric (stomach cancerBTG International LtdDesignated
Dec 10, 200420-mer complementary to Akt mRNATreatment of stomach cancerRexahn CorporationDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.